| Recent advances in asymmetric hydrogenation of tetrasubstituted olefins S Kraft, K Ryan, RB Kargbo Journal of the American Chemical Society 139 (34), 11630-11641, 2017 | 150 | 2017 |
| Readily accessible, modular, and tuneable BINOL 3, 3 ‘-perfluoroalkylsulfones: Highly efficient catalysts for enantioselective In-mediated imine allylation R Kargbo, Y Takahashi, S Bhor, GR Cook, GC Lloyd-Jones, ... Journal of the American Chemical Society 129 (13), 3846-3847, 2007 | 115 | 2007 |
| Stereoselective indium-mediated allylation reactions RB Kargbo, GR Cook Current Organic Chemistry 11 (15), 1287-1309, 2007 | 80 | 2007 |
| Highly diastereoselective indium-mediated allylation of chiral hydrazones GR Cook, BC Maity, R Kargbo Organic Letters 6 (11), 1741-1743, 2004 | 80 | 2004 |
| Synthesis and biological evaluation of tryptamines found in hallucinogenic mushrooms: norbaeocystin, baeocystin, norpsilocin, and aeruginascin AM Sherwood, AL Halberstadt, AK Klein, JD McCorvy, KW Kaylo, ... Journal of natural products 83 (2), 461-467, 2020 | 76 | 2020 |
| Catalytic enantioselective indium-mediated allylation of hydrazones GR Cook, R Kargbo, B Maity Organic Letters 7 (13), 2767-2770, 2005 | 75 | 2005 |
| PROTAC compounds targeting α-synuclein protein for treating neurogenerative disorders: Alzheimer’s and Parkinson’s diseases RB Kargbo ACS Medicinal Chemistry Letters 11 (6), 1086-1087, 2020 | 62 | 2020 |
| Treatment of Alzheimer’s by PROTAC-Tau protein degradation RB Kargbo ACS medicinal chemistry letters 10 (5), 699-700, 2019 | 60 | 2019 |
| Direct phosphorylation of psilocin enables optimized cGMP kilogram-scale manufacture of psilocybin RB Kargbo, A Sherwood, A Walker, NV Cozzi, RE Dagger, J Sable, ... ACS omega 5 (27), 16959-16966, 2020 | 38 | 2020 |
| Psilocybin therapeutic research: the present and future paradigm RB Kargbo ACS medicinal chemistry letters 11 (4), 399-402, 2020 | 35 | 2020 |
| Asymmetric synthesis of aminochromanes via intramolecular indium-mediated allylation of chiral hydrazones D Samanta, RB Kargbo, GR Cook The Journal of organic chemistry 74 (18), 7183-7186, 2009 | 34 | 2009 |
| Scalable hybrid synthetic/biocatalytic route to psilocybin J Fricke, R Kargbo, L Regestein, C Lenz, G Peschel, MA Rosenbaum, ... Chemistry–A European Journal 26 (37), 8281-8285, 2020 | 33 | 2020 |
| Neuroactive steroids, compositions, and uses thereof GM BOTELLA, BL Harrison, AJ Robichaud, FG Salituro, RJ Herr, ... US Patent App. 14/913,920, 2016 | 32 | 2016 |
| Efficient one-pot synthesis of 2-substituted benzimidazoles from triacyloxyborane intermediates W Cui, RB Kargbo, Z Sajjadi-Hashemi, F Ahmed, JF Gauuan Synlett 2012 (02), 247-250, 2012 | 30 | 2012 |
| PROTAC-mediated degradation of estrogen receptor in the treatment of cancer RB Kargbo ACS Medicinal Chemistry Letters 10 (10), 1367-1369, 2019 | 29 | 2019 |
| Taking Different Roads: l‐Tryptophan as the Origin of Psilocybe Natural Products C Lenz, A Sherwood, R Kargbo, D Hoffmeister ChemPlusChem 86 (1), 28-35, 2021 | 25 | 2021 |
| Enzymatic route toward 6‐methylated baeocystin and psilocybin J Fricke, A Sherwood, R Kargbo, A Orry, F Blei, A Naschberger, B Rupp, ... ChemBioChem 20 (22), 2824-2829, 2019 | 24 | 2019 |
| An improved, practical, and scalable five-step synthesis of psilocybin AM Sherwood, P Meisenheimer, G Tarpley, RB Kargbo Synthesis 52 (05), 688-694, 2020 | 20 | 2020 |
| PROTAC-mediated degradation of KRAS protein for anticancer therapeutics RB Kargbo ACS Medicinal Chemistry Letters 11 (1), 5-6, 2019 | 20 | 2019 |
| Treatment of Cancer and Alzheimer’s Disease by PROTAC Degradation of EGFR RB Kargbo ACS Medicinal Chemistry Letters 10 (8), 1098-1099, 2019 | 20 | 2019 |
Gregory CookNorth Dakota State University在 ndsu.edu 的电子邮件经过验证
